Gentiva Health Services, Inc.  

(Public, NASDAQ:GTIV)   Watch this stock  
Find more results for GTIV
16.92
-0.49 (-2.81%)
Sep 23 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 16.71 - 17.58
52 week 7.35 - 18.93
Open 17.30
Vol / Avg. 251,501.00/290,198.00
Mkt cap 642.35M
P/E     -
Div/yield     -
EPS -11.07
Shares 36.90M
Beta 1.43
Inst. own 78%
Nov 3, 2014
Q3 2014 Gentiva Health Services Inc Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Aug 5, 2014
Q2 2014 Gentiva Health Services Earnings Release
Aug 5, 2014
Q2 2014 Gentiva Health Services Inc Earnings Call
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 2.01% -34.66%
Operating margin 3.39% -36.95%
EBITD margin - 7.55%
Return on average assets 3.23% -43.16%
Return on average equity - -
Employees 39,200 -
CDP Score - -

Address

Suite 1400, 3350 Riverwood Parkway
ATLANTA, GA 30339
United States - Map
+1-770-9516450 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Gentiva Health Services, Inc. (Gentiva) is engaged in providing home health services and hospice services. The Company provides a single source for nursing; physical, occupational, speech and neurorehabilitation services; hospice services; social work; nutrition; disease management education; help with daily living activities and other therapies and services. The Company operates in two segments: Home Health and its Hospice segment. As of December 31, 2011, the Company served patients through approximately 420 locations in 41 states. During the year ended December 31, 2011, the Company sold its equity investment in CareCentrix Holdings Inc. During 2011, the Company closed or divested 34 home health branches and 9 hospice branches. In October 2013, the Company acquired Harden Healthcare Holdings, Inc.

Officers and directors

Rodney D. Windley Executive Chairman of the Board
Age: 66
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
David A. Causby President, Chief Operating Officer
Age: 42
Bio & Compensation  - Reuters
Tony Strange Chief Executive Officer, Director
Age: 51
Bio & Compensation  - Reuters
R Steven Hicks Vice Chairman of the Board
Bio & Compensation  - Reuters
Eric R. Slusser Chief Financial Officer, Executive Vice President, Treasurer
Age: 53
Bio & Compensation  - Reuters
John N. Camperlengo Senior Vice President, General Counsel, Secretary
Age: 50
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Jeff Shaner Senior Vice President; president - operations
Age: 41
Bio & Compensation  - Reuters
Charlotte A. Weaver Senior Vice President, Chief Clinical Officer
Age: 66
Bio & Compensation  - Reuters
Victor F. Ganzi Lead Independent Director
Age: 67
Bio & Compensation  - Reuters
Robert S. Forman Jr. Independent Director
Age: 74
Bio & Compensation  - Reuters